PCH
AVDL

Polar Capital Holdings’s Avadel Pharmaceuticals AVDL Stock Holding History

Polar Capital Holdings’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,999,338
Closed -$61.1M – 268
2025
Q3 		$61.1M Hold
3,999,338
– – 0.29% 87
2025
Q2 		$35.4M Sell
3,999,338
-356,626
-8% -$3.13M 0.19% 107
2025
Q1 		$34.1M Sell
4,355,964
-58,236
-1% -$488K 0.21% 117
2024
Q4 		$46.4M Sell
4,414,200
-419,828
-9% -$5.1M 0.26% 96
2024
Q3 		$63.4M Sell
4,834,028
-1,726,387
-26% -$26.3M 0.3% 70
2024
Q2 		$92.2M Sell
6,560,415
-193,257
-3% -$3.15M 0.54% 50
2024
Q1 		$114M Buy
6,753,672
+1,890
+0% +$28.1K 0.6% 39
2023
Q4 		$95.3M Buy
6,751,782
+2,238,818
+50% +$26.3M 0.58% 49
2023
Q3 		$46.5M Sell
4,512,964
-21,957
-0.5% -$294K 0.34% 79
2023
Q2 		$74.7M Sell
4,534,921
-37,569
-0.8% -$488K 0.38% 67
2023
Q1 		$41.9M Buy
4,572,490
+1,760,000
+63% +$14.5M 0.27% 92
2022
Q4 		$20.1M Hold
2,812,490
– – 0.16% 148
2022
Q3 		$14.1K Hold
2,812,490
– – 0.09% 165
2022
Q2 		$6.86K Sell
2,812,490
-386,662
-12% -$1.59M 0.04% 223
2022
Q1 		$21.9K Buy
3,199,152
+404,479
+14% +$2.78M 0.1% 163
2021
Q4 		$22.6K Hold
2,794,673
– – 0.08% 160
2021
Q3 		$27.4K Hold
2,794,673
– – 0.11% 145
2021
Q2 		$18.8K Hold
2,794,673
– – 0.08% 174
2021
Q1 		$25.3M Sell
2,794,673
-233,032
-8% -$1.88M 0.16% 136
2020
Q4 		$20.2M Buy
+3,027,705
New +$18.9M 0.12% 157

Other funds holding AVDL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Polar Capital Holdings's AVDL Position: Q4 2025 in Review

Polar Capital Holdings sold out of Avadel Pharmaceuticals (AVDL) in Q4 2025, closing a stake of 3,999,338 shares — an estimated $61.1M sold.

Polar Capital Holdings first reported a position in AVDL in Q4 2020 and held it in 20 quarters. The position peaked at $114M in Q1 2024. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

  • Polar Capital Holdings reported no remaining Avadel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Polar Capital Holdings sold 3,999,338 Avadel Pharmaceuticals shares in Q4 2025, an estimated $61.1M.
  • Polar Capital Holdings first reported a position in Avadel Pharmaceuticals in Q4 2020 and held it in 20 quarters.
  • Polar Capital Holdings's Avadel Pharmaceuticals position peaked at $114M in Q1 2024.
  • 207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on Polar Capital Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.